亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Pharmacotherapy for social anxiety disorder: a systematic review

医学 随机对照试验 社交焦虑 焦虑 科克伦图书馆 安慰剂 精神科 不利影响 药物治疗 心理信息 梅德林 系统回顾 内科学 替代医学 政治学 法学 病理
作者
Jonathan Ipser,Catherine M Kariuki,Dan Joseph Stein
出处
期刊:Expert Review of Neurotherapeutics [Taylor & Francis]
卷期号:8 (2): 235-257 被引量:70
标识
DOI:10.1586/14737175.8.2.235
摘要

Social anxiety disorder (SAD) is a prevalent, disabling disorder. We aimed to assess the effects of pharmacotherapy for SAD and to determine whether particular classes of medication are more effective and/or better tolerated than others. A systematic review and meta-analysis was conducted of all published and unpublished placebo-controlled randomized controlled trials (RCTs) undertaken between 1966 and 2007. A rigorous search, which included searching the Cochrane CCDANTR, MEDLINE and PsycINFO electronic databases, yielded a total of 51 RCTs (9914 participants) considered eligible for inclusion in the review. On average, over half of trial participants responded to medication, as assessed with the improvement item of the Clinical Global Impressions scale (55.2%), with approximately four participants having to be treated for an average of 12 weeks before an additional person responded to medication, relative to placebo (number needed to benefit = 4.19). There was substantial variation across medication classes in the number of dropouts due to adverse events, with an average number needed to harm of 14.4. Maintenance and relapse prevention studies confirm the value of longer-term medication in treatment responders. Medication was also effective in reducing SAD symptoms, comorbid depressive symptoms and associated disability. However, evidence for the efficacy of beta-blockers in treating performance anxiety was lacking. Taken together, trials of selective serotonin reuptake inhibitors and serotonin-norepinephrine reuptake inhibitors provide the largest evidence base for agents that are both effective and well tolerated. This review is an updated version of a Cochrane Review in The Cochrane Library, Issue 4, 2004. Cochrane Reviews are regularly updated as new evidence emerges and in response to feedback, and The Cochrane Library should be consulted for the most recent version of the review.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
渡人舟的应助被科研通管家采纳,获得10
4秒前
乐乐的应助被科研通管家采纳,获得10
4秒前
null的应助被科研通管家采纳,获得10
4秒前
16秒前
20秒前
科研通AI6.2的应助被纯情的阁采纳,获得10
28秒前
老实的石头完成签到,获得积分10
36秒前
霸气祥完成签到,获得积分10
36秒前
超帅的半莲完成签到,获得积分10
36秒前
47秒前
369ninja发布了新的文献求助10
53秒前
null的应助被纯情的阁采纳,获得10
1分钟前
null的应助被纯情的阁采纳,获得10
1分钟前
fairytaler的应助被纯情的阁采纳,获得10
1分钟前
1分钟前
范特西完成签到 ,获得积分10
1分钟前
1分钟前
缓慢的雨筠完成签到,获得积分10
1分钟前
幽默的萍完成签到,获得积分10
1分钟前
1分钟前
爱笑美女完成签到,获得积分10
2分钟前
犹豫擎苍完成签到,获得积分10
2分钟前
null的应助被科研通管家采纳,获得10
2分钟前
null的应助被科研通管家采纳,获得10
2分钟前
2分钟前
madeleinli的应助被纯情的阁采纳,获得10
2分钟前
慕青的应助被纯情的阁采纳,获得10
2分钟前
madeleinli的应助被纯情的阁采纳,获得10
2分钟前
科研通AI6.2的应助被纯情的阁采纳,获得10
2分钟前
2分钟前
科研通AI6.2的应助被纯情的阁采纳,获得10
2分钟前
小蘑菇的应助被纯情的阁采纳,获得10
2分钟前
科研通AI6.2的应助被纯情的阁采纳,获得10
2分钟前
科研通AI6.2的应助被纯情的阁采纳,获得10
2分钟前
2分钟前
单纯冰菱完成签到,获得积分10
2分钟前
2分钟前
火星上的山柳完成签到,获得积分10
2分钟前
2分钟前
大个的应助被Eva小飞鱼采纳,获得10
3分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8158827
求助须知:如何正确求助?哪些是违规求助? 9554476
关于积分的说明 21719316
捐赠科研通 7748395
什么是DOI,文献DOI怎么找? 3427099
关于科研通互助平台的介绍 2552000
邀请新用户注册赠送积分活动 2471370